BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9858293)

  • 1. Altered radiopharmaceutical distribution in myeloma: bone tracer in the heart and heart tracer in the bone.
    Gupta AK; Meyer P; Gross MD; Fig LM; Shapiro B
    Clin Nucl Med; 1998 Dec; 23(12):820-3. PubMed ID: 9858293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-MDP SPECT/CT demonstrating extraosseous periarticular amyloid deposits in primary systemic amyloidosis associated with multiple myeloma.
    Agarwal KK; Karunanithi S; Roy SG; Bal C; Kumar R
    Clin Nucl Med; 2015 Feb; 40(2):189-90. PubMed ID: 25275414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked soft tissue uptake of bone tracer in a patient with amyloidosis and multiple myeloma.
    Posch TJ; Olson SP
    Clin Nucl Med; 1992 Nov; 17(11):909. PubMed ID: 1424388
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered biodistribution of bone seeking agents in the presence of iron-overload.
    Pérez-Lago Mdel S; De Vírgala MC; Siurana R; Ferrando MJ; Danús M; Izquierdo V; Pujol A
    Clin Nucl Med; 2004 Mar; 29(3):214-6. PubMed ID: 15162998
    [No Abstract]   [Full Text] [Related]  

  • 5. Tc-99m HDP uptake in cardiac amyloidosis.
    Wadhwa SS; Nour R
    Clin Nucl Med; 1999 Mar; 24(3):156-8. PubMed ID: 10069722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
    Berk F; Demir H; Hacihanefioglu A; Arslan A; Erdincler O; Isgoren S; Aktolun C
    Ann Nucl Med; 2002 Apr; 16(2):137-41. PubMed ID: 12043908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absent skeletal uptake of (99m)Tc-hydroxymethylene diphosphonate in the presence of AL-type amyloidosis associated with multiple myeloma.
    Sasaki T; Okizaki A; Takahashi K; Mineta M; Nagasawa K; Fujimoto Y; Kohda K; Aburano T
    Jpn J Radiol; 2011 Oct; 29(8):595-7. PubMed ID: 21928004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone scintigraphy with (99m)technetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis.
    Glaudemans AW; van Rheenen RW; van den Berg MP; Noordzij W; Koole M; Blokzijl H; Dierckx RA; Slart RH; Hazenberg BP
    Amyloid; 2014 Mar; 21(1):35-44. PubMed ID: 24455993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes in myocardial uptake on serial bone scans in two cases of presumed senile cardiac amyloidosis.
    Davidson RM; Lin DS; Klima M
    Clin Nucl Med; 1993 Oct; 18(10):858-62. PubMed ID: 8242978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.
    Singh V; Falk R; Di Carli MF; Kijewski M; Rapezzi C; Dorbala S
    J Nucl Cardiol; 2019 Feb; 26(1):158-173. PubMed ID: 30569412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with cardiac amyloidosis presenting a rapid increase in technetium-99m-hydroxymethylene diphosphonate accumulation.
    Kobayashi T; Sekiya M; Fujiwara Y; Sumimoto T; Matsuoka H; Hamada M; Hiwada K
    Ann Nucl Med; 1993 Nov; 7(4):273-6. PubMed ID: 8292455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Technetium-99m-pyrophosphate single photon emission computed tomography of the heart in familial amyloid polyneuropathy: comparison with thallium-201 myocardial scintigraphy--a case report].
    Imamoto T; Morita K; Onodera S; Tanazawa S; Amoh K; Ishikawa Y; Murakami N; Kawachi H
    Kaku Igaku; 1988 Oct; 25(10):1117-23. PubMed ID: 2851670
    [No Abstract]   [Full Text] [Related]  

  • 13. Technetium-99m (Tc-99m) diphosphono-propanedicarboxylic acid bone tracer uptake and Tc-99m sestamibi distribution in cardiac amyloidosis--a case report.
    Low YH; Ang ES; Goh AS; Sundram FX; Sin FL
    Ann Acad Med Singap; 1995 Nov; 24(6):898-901. PubMed ID: 8839006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac scintigraphy with
    de Haro-Del Moral FJ; Pubul-Núñez V; Casáns-Tormo I; Jiménez-Heffernan A; Ruano-Pérez R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(4):254-266. PubMed ID: 32513587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thoracic soft tissue uptake on a bone scintigraphy. 2 cases].
    Biyi A; Doudouh A; Farik M; Zekri A
    Rev Pneumol Clin; 2006 Sep; 62(4):237-42. PubMed ID: 17075548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imagine, believe, and achieve.
    Peix A; Padrón K
    J Nucl Cardiol; 2021 Jun; 28(3):831-834. PubMed ID: 33963494
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse facial uptake on bone scintigraphy.
    Brans B; Verzijlbergen JF
    Semin Nucl Med; 2000 Jan; 30(1):70-3. PubMed ID: 10656247
    [No Abstract]   [Full Text] [Related]  

  • 18. Soft-tissue uptake of technetium-99m MDP in multiple myeloma.
    Kanoh T; Uchino H; Yamamoto I; Torizuka K
    Clin Nucl Med; 1986 Dec; 11(12):878-9. PubMed ID: 3815990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive soft tissue uptake of 99Tcm methylene diphosphonate in a patient with multiple myeloma.
    Evans JC; Murphy M; Eyes B
    Br J Radiol; 2000 Sep; 73(873):1018-20. PubMed ID: 11064661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentavalent technetium-99m-DMSA uptake in a patient having multiple myeloma without amyloidosis.
    Ohnishi T; Noguchi S; Murakami N; Tajiri J; Morita M; Tamaru M; Hoshi H; Watanabe K
    J Nucl Med; 1991 Sep; 32(9):1785-7. PubMed ID: 1652629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.